Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 7, 2005, Pages 832-835

  Lee, Seon A ^a   Hong, Seong Su ^a   Han, Xiang Hua ^a   Hwang, Ji Sang ^a   Oh, Gab Jin ^b   Lee, Kyong Soon ^a   Lee, Myung Koo ^a   Hwang, Bang Yeon ^a   Ro, Jai Seup ^a  

^a Chungbuk National University   (South Korea)

^b Samil Pharmaceutical Co Ltd   (South Korea)

Author keywords

Antidepressant agent; Monoamine oxidase inhibitor; Piper longum; Piperine

Indexed keywords

ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; PIPER LONGUM EXTRACT; PIPERINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CONTROLLED STUDY; DIALYSIS; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; ENZYME INHIBITION; FRUIT; IC 50; INCUBATION TIME; KINETICS; MOBILIZATION; OPEN FIELD BEHAVIOR;

ALKALOIDS; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZODIOXOLES; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; PIPER; PIPERIDINES; POLYUNSATURATED ALKAMIDES;

EID: 24944476938     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.53.832     Document Type: Article

References (27)

1. Shih J. C., Chen K., Ridd M. J., Annu. Rev. Neurosci., 22, 197-217 (1999).
2. Bach A. W., Lan N. C., Johnson D. L., Abell C. W., Bembenek M. E., Kwan S. W., Seeburg P. H., Shih J. C., Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938 (1988).
3. Abell C. W., Kwan S. W., Prog. Nucl. Acids Res. Mol. Biol., 65, 129-156 (2001).
4. Kalgutkar A. S., Castagnoli N. Jr., Med. Res. Rev., 15, 325-388 (1995).
5. Jegham S., George P., Exp. Opin. Ther. Patents, 8, 1143-1150 (1998).
6. Gnerre C., Catto M., Leonetti F., Weber P., Carrupt P. A., Altomare C., Carotti A., Testa B., J. Med. Chem., 43, 4747-4758 (2000).
7. Suzuki O., Katsumata Y., Oya M., Chari V. M., Vermes B., Wagner H., Hostettmann K., Planta Med., 42, 17-21 (1981).
8. Ro J. S., Lee S. S., Lee K. S., Lee M. K., Life Sci., 70, 639-645 (2001).
9. Kong L. D., Cheng C. H., Tan R. X., Planta Med., 67, 74-76 (2001).
10. Parmar V. S., Jain S. C., Bisht K. S., Jain R., Taneja P., Jha A., Tyagi O. M., Prasad A. K., Wengel J., Olsen C. E., Boll P. M., Phytochemistry, 46, 597-673 (1997).
11. Jung B. S., Shin M. K., "Encyclopedia of Illustrated Korean Natural Drugs," Young Lim Sa, Seoul, 1989, pp. 818-819.
12. Lee E. B., Shin K. H., Woo W. S., Arch. Pharm. Res., 7, 127-132 (1984).
13. Woo W. S., Lee E. B., Shin K. H., Arch. Pharm. Res., 2, 121-125 (1979).
14. Pei Y. Q., Epilepsia, 24, 177-182 (1983).
15. Tabuneng W., Bando H., Amiya T., Chem. Pharm. Bull., 31, 3562-3565 (1983).
16. De Araujo-Junior J. X., Da-Cunha E. V. L., De O. Chaves M. C., Gray A. I., Phytochemistry, 44, 559-561 (1997).
17. Kong L. D., Cheng C. H. K., Tan R. X., J. Ethnopharmacol., 91, 351-355 (2004).
18. Da Prada M., Kettler R., Keller H. H., Cesura A. M., Richards J. G., Saura Marti J., Muggli-Maniglio D., Wyss P. C., Kyburz E., Imhof R., J. Neural. Transm. Suppl., 29, 279-292 (1990).
19. Porsolt R. D., Le Pichon M., Jalfre M., Nature (London), 266, 730-732 (1977).
20. Steru L., Chermat R., Thierry B., Simon P., Psychopharmacology, 85, 367-370 (1985).
21. Porsolt R. D., Anton G., Blavet N., Jalfre M., Eur. J. Pharmacol., 47, 379-391 (1978).
22. Willner P., Psychopharmacology, 83, 1-16 (1984).
23. Kapur S., Mann J. J., Biol. Psychiatry, 32, 1-17 (1992).
24. Lee M. K., Hwang B. Y., Lee S. A., Oh G. J., Choi W. H., Hong S. S., Lee K. S., Ro J. S., Chem. Pharm. Bull., 51, 409-411 (2003).
25. Naoi M., Nagatsu T., J. Neurochem., 46, 655-657 (1986).
26. Kraml M., Biochem. Pharmacol., 14, 1684-1686 (1965).
27. Kulkarni S. K., Dandiya P. C., Psychopharmacologia, 33, 333-338 (1973).